ClinicalTrials.Veeva

Menu

Genetic Study of Patients With Primary Ciliary Dyskinesia

N

National Center for Research Resources (NCRR)

Status

Completed

Conditions

Primary Ciliary Dyskinesia

Study type

Observational

Funder types

Other
NIH

Identifiers

NCT00005650
UNCCH-GCRC-1395
NCRR-M01RR00046-1395

Details and patient eligibility

About

OBJECTIVES:

I. Characterize the clinical presentation of patients with primary ciliary dyskinesia.

II. Identify the genetic mutations associated with this disease.

Full description

PROTOCOL OUTLINE:

Participants undergo a scrape biopsy acquisition of nasal cells for ciliary studies, a chest radiograph, sinus radiographs, lung function tests, sputum cultures, nitric oxide measurement, and an ear, nose and throat evaluation to screen for primary ciliary dyskinesia (PCD). Blood collection and/or a buccal scrape is also performed for genetic studies.

Genetic studies include molecular linkage analyses, genetic mapping, and gene mutation identification based on large deletions. Microsatellite markers are used to identify polymorphism.

Genetic counseling is provided to all participants.

Sex

All

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

  • Histologically or cytologically confirmed primary ciliary dyskinesia (PCD)
  • Family members of patients with PCD

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems